Corporate Banner
Satellite Banner
Crystallography
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Rigaku and Emerald Bio Announce Strategic Alliance

Published: Thursday, August 01, 2013
Last Updated: Thursday, August 01, 2013
Bookmark and Share
Partnership to broaden customer solutions in protein crystallography.

Rigaku has acquired the crystallization reagent and consumable business, including the popular Wizard™ screens, from Emerald Bio, a world leader in protein science. In addition, both companies have agreed to work together to develop new products and solutions in the growing field of protein science.

“The addition of these consumables and screening kits is another step in creating a single contact point for our instrumentation customers, improving the efficiency of their workflow,” stated Catherine Klein, president of Rigaku Americas Corporation’s Life Sciences Division.  “Further, having Emerald Bio as a development partner and customer will help ensure that we are at the forefront of new product needs in protein science.”

“Having Rigaku, the world leading protein crystallography instrumentation company, as a development partner is ideal for Emerald,” said Johan Pontin, CEO of Emerald Bio.  “While we focus on our growing consulting solutions business,” said George Abe, president of Emerald Bio, “we can rely on Rigaku to support our own internal workflow needs and we now have a partner to build integrated solutions, including software, for our mutual customers.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Rigaku Announce New President & COO
Company appoints Mr. Yoichi Yokomizo as Chief Operating Officer of RAH.
Tuesday, April 07, 2015
Rigaku to Acquire Agilent’s X-Ray Diffraction Business
Company plans to combine XRD with its existing crystallography business to form a new business unit.
Wednesday, April 01, 2015
European Crystallography Meeting delegates Raise Money for Charity
Cycling enthusiasts at the 28th European Crystallography Meeting (ECM) have used the occasion to raise money for Cancer Research.
Wednesday, October 02, 2013
Texas State University Acquires Rigaku SCXmini Chemical Crystallography Instrument
The University has purchased the benchtop small molecule XRD crystallography instrument for Cyber-enabled for cyber-enabled teaching and research.
Thursday, January 08, 2009
Monash University Purchases Rigaku CrystalMation system for The Protein Crystallography Unit
The system is chosen in support of macromolecular crystallographic studies carried out by researchers at Monash University and their collaborative partners.
Friday, September 26, 2008
Rigaku Wins "Most Innovative New Technology" Award for CrystalMation™ and Desktop Minstrel™ UV Products
Company receives award for the Rigaku Desktop Minstrel UV system and Rigaku CrystalMation system at the ELRIG Protein Crystallography Conference.
Wednesday, April 23, 2008
Rigaku Sponsors Carl Brändén Award
The 2007 Carl Brändén Award was presented to Prof. Lubert Stryer for his exceptional contributions to education in biochemistry and molecular biology.
Monday, June 04, 2007
Rigaku Leads in Protein Structure Productivity Based on Analysis of Protein Data Bank Submissions
Data show that structures solved with Rigaku home laboratory X-ray generators comprised 17% of all submitted structures for 2005.
Wednesday, March 07, 2007
Rigaku Launches new Corporate Website
The website integrates all Rigaku products and business units with a common look and feel for an enhanced Internet browsing experience.
Wednesday, November 01, 2006
Rigaku Announces Reorganization
Rigaku Americas Corporation became the operating entity in charge of North America.
Tuesday, October 18, 2005
Scientific News
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
Drug Design Strategy to Improve Breast Cancer Treatment
Scientists develop novel structure-based drug design strategy aimed at altering the basic landscape of hormone-driven breast cancer treatment.
Crystals, Super Magnets in Drug Discovery
Scientists have produced larger superparamagnetic crystals that could revolutionise drug delivery.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Snapshots of Chemical Flipping a Biological Switch
X-ray laser gets first real-time snapshots of a chemical flipping a biological switch, opening new path to understanding how RNA works.
Uncovering Elusive Proteins
Researchers have determined the complete structure of elusive proteins, known as tetraspanins, for the first time.
Cannabinoid Receptor Structure Revealed
Scientists provided a detailed view of the primary molecule through which cannabinoids exert their effects on the brain. The findings might help guide the design of more targeted medicines with fewer side effects.
Alzheimer’s Treatment Moves a Step Closer
Merck scientists have reported the discovery of verubecestat, a structurally unique, orally bioavailable small molecule that has been shown to target the most visible sign of the disease in the brain.
Study Unocovers Cancer-Linked Protein’s Associates
Researchers have developed a new list of nearly 100 potential partners of a cancer-linked enzyme by studying its interactions with other proteins.
Scientists Uncover Why Hepatitis C Vaccine is Difficult to Make
Scientists have uncovered one reason why a successful hepatitis C vaccine continues to be elusive.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!